Literature DB >> 8676333

N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.

J D Higgins1, G J Bridger, C K Derian, M J Beblavy, P E Hernandez, F E Gaul, M J Abrams, M C Pike, H F Solomon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8676333     DOI： 10.1021/jm950908d

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  5 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

2.  A novel fluorescent cross-reactive formylpeptide receptor/formylpeptide receptor-like 1 hexapeptide ligand.

Authors:  J Jacob Strouse; Susan M Young; Hugh D Mitchell; Richard D Ye; Eric R Prossnitz; Larry A Sklar; Bruce S Edwards
Journal:  Cytometry A       Date:  2009-03       Impact factor: 4.355

Review 3.  Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury.

Authors:  Junaid Ansari; Gaganpreet Kaur; Felicity N E Gavins
Journal:  Int J Mol Sci       Date:  2018-04-16       Impact factor: 5.923

Review 4.  Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury?

Authors:  Felicity N E Gavins
Journal:  Trends Pharmacol Sci       Date:  2010-05-17       Impact factor: 14.819

5.  Variable responses of formyl peptide receptor haplotypes toward bacterial peptides.

Authors:  Jeannie M Gripentrog; John S Mills; George J Saari; Heini M Miettinen
Journal:  Immunogenetics       Date:  2008-02-06       Impact factor: 2.846
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.